Mahsa Ghajarzadeh, Yishang Huang, Ellen M Mowry, Kathryn C Fitzgerald, Bardia Nourbakhsh
{"title":"Baseline physical and cognitive functions associate with the longitudinal trajectory of stigma in patients with multiple sclerosis (MS)","authors":"Mahsa Ghajarzadeh, Yishang Huang, Ellen M Mowry, Kathryn C Fitzgerald, Bardia Nourbakhsh","doi":"10.1016/j.msard.2025.106367","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Multiple sclerosis is a chronic disease, and the lived experience of a person with MS is highly heterogeneous.</div></div><div><h3>Objective</h3><div>To analyze longitudinal trajectories of stigma in MS, the associated baseline predictors, and how the stigma trajectories relate to the longitudinal changes in physical disability.</div></div><div><h3>Method</h3><div>In a cohort of people from the MS Partners Advancing Technology and Health Solutions (MS PATHS) network with at least two stigma measures, we analyzed the trajectory of stigma and physical disability by applying a group-based trajectory modeling (GBTM) to longitudinal measures of Neuro-QoL stigma T-score and Patient Determined Disease Steps (PDDS), respectively.</div></div><div><h3>Results</h3><div>We included 8,404 MS PATHS participants with a mean follow-up duration of 2.8 ± 1.4 years. We found four stigma trajectories, which remained stable over the follow-up period. Compared to the no stigma trajectory group, the odds of being in the high stigma group were higher in people with higher baseline PDDS (OR=1.9, 95 % CI: 1.7–2.1) and stigma (OR=2.4, 95 % CI: 2.3–2.5), and worse processing speed test scores (OR=0.7, 95 % CI: 0.6–0.8). The trajectory of stigma was strongly associated with the PDDS trajectory.</div></div><div><h3>Conclusions</h3><div>Baseline severity of stigma, physical disability, and performance on the processing speed test were the strongest predictors of belonging to a higher stigma trajectory group.</div></div>","PeriodicalId":18958,"journal":{"name":"Multiple sclerosis and related disorders","volume":"96 ","pages":"Article 106367"},"PeriodicalIF":2.9000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multiple sclerosis and related disorders","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211034825001105","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Multiple sclerosis is a chronic disease, and the lived experience of a person with MS is highly heterogeneous.
Objective
To analyze longitudinal trajectories of stigma in MS, the associated baseline predictors, and how the stigma trajectories relate to the longitudinal changes in physical disability.
Method
In a cohort of people from the MS Partners Advancing Technology and Health Solutions (MS PATHS) network with at least two stigma measures, we analyzed the trajectory of stigma and physical disability by applying a group-based trajectory modeling (GBTM) to longitudinal measures of Neuro-QoL stigma T-score and Patient Determined Disease Steps (PDDS), respectively.
Results
We included 8,404 MS PATHS participants with a mean follow-up duration of 2.8 ± 1.4 years. We found four stigma trajectories, which remained stable over the follow-up period. Compared to the no stigma trajectory group, the odds of being in the high stigma group were higher in people with higher baseline PDDS (OR=1.9, 95 % CI: 1.7–2.1) and stigma (OR=2.4, 95 % CI: 2.3–2.5), and worse processing speed test scores (OR=0.7, 95 % CI: 0.6–0.8). The trajectory of stigma was strongly associated with the PDDS trajectory.
Conclusions
Baseline severity of stigma, physical disability, and performance on the processing speed test were the strongest predictors of belonging to a higher stigma trajectory group.
期刊介绍:
Multiple Sclerosis is an area of ever expanding research and escalating publications. Multiple Sclerosis and Related Disorders is a wide ranging international journal supported by key researchers from all neuroscience domains that focus on MS and associated disease of the central nervous system. The primary aim of this new journal is the rapid publication of high quality original research in the field. Important secondary aims will be timely updates and editorials on important scientific and clinical care advances, controversies in the field, and invited opinion articles from current thought leaders on topical issues. One section of the journal will focus on teaching, written to enhance the practice of community and academic neurologists involved in the care of MS patients. Summaries of key articles written for a lay audience will be provided as an on-line resource.
A team of four chief editors is supported by leading section editors who will commission and appraise original and review articles concerning: clinical neurology, neuroimaging, neuropathology, neuroepidemiology, therapeutics, genetics / transcriptomics, experimental models, neuroimmunology, biomarkers, neuropsychology, neurorehabilitation, measurement scales, teaching, neuroethics and lay communication.